Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of imiquimod 5% cream after lentigo maligna excision
2010-019422-13Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jul 2010
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imiquimod in lentigo maligna (LM), sponsored by Medical University of Graz. Started Jul 2010; status: completed.
02
Drugs
imiquimod
03
Conditions
lentigo maligna (LM)
Beyond the preview
Go deeper on 2010-019422-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019422-13.